Patient perspective of participation in COVID-19 clinical trials
K. Krassowska (Oxford, United Kingdom), C. Mwasuku (Oxford, United Kingdom), S. Ramakrishnan (Oxford, United Kingdom), B. Langford (Oxford, United Kingdom), H. Jeffers (Oxford, United Kingdom), M. Mahdi (Oxford, United Kingdom), R. Russell (Oxford, United Kingdom), M. Bafadhel (Oxford, United Kingdom)
Source: Virtual Congress 2021 – Innovations in nurse-led interventions in respiratory diseases
Rating:
You must login to grade this presentation.
Share or cite this content
Citations should be made in the following way:
K. Krassowska (Oxford, United Kingdom), C. Mwasuku (Oxford, United Kingdom), S. Ramakrishnan (Oxford, United Kingdom), B. Langford (Oxford, United Kingdom), H. Jeffers (Oxford, United Kingdom), M. Mahdi (Oxford, United Kingdom), R. Russell (Oxford, United Kingdom), M. Bafadhel (Oxford, United Kingdom). Patient perspective of participation in COVID-19 clinical trials. 1803
You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
Related content which might interest you:
Related content which might interest you: